FDA Scrutinizes Telehealth Firms Like Hims for GLP-1 Drug Advertising Practices
FDA; Hims; telehealth; GLP-1; advertising; weight-loss drugs; compound drugs; Super Bowl ad; misleading claims
J&J’s Oral IL-23 Drug Icotrokinra Surpasses Sotyktu in Phase 3 Psoriasis Trials
Icotrokinra; JNJ-2113; Johnson & Johnson; IL-23 receptor antagonist; Sotyktu; deucravacitinib; plaque psoriasis; Phase 3 clinical trial; skin clearance; oral peptide; Bristol Myers Squibb
FDA Cracks Down on Misleading Drug Ads in Major Pharmaceutical Companies
FDA; Misleading Drug Ads; Pharmaceutical Companies; Crackdown
Ollin Biosciences Launches with $100M to Challenge Roche in Eye Disease Market
Ollin Biosciences; Roche; eye disease; biotech; VEGF-A; Ang2; wet AMD; diabetic macular edema; clinical trial; OLN324; Vabysmo
Eli Lilly’s Oral GLP-1 Orforglipron Outperforms Semaglutide in Diabetes and Weight Loss Trials
Lilly; orforglipron; oral GLP-1; semaglutide; type 2 diabetes; weight loss; phase 3 trial; Novo Nordisk
Next-Generation Psoriasis Drugs Aim to Reshape Treatment Landscape
psoriasis; next-generation biologics; icotrokinra; IL-23 inhibitors; oral peptides; TYK2 inhibitors; vunakizumab; piclidenoson; clinical trials; FDA approval
Eli Lilly Announces $5B Manufacturing Plant in Virginia, Creating Nearly 2,500 Jobs
Eli Lilly; Virginia; $5 billion; manufacturing plant; 2,500 jobs; Richmond; biotech industry
Genmab Abandons ADC Asset Acquired in $1.8B ProfoundBio Deal
Genmab; ProfoundBio; antibody-drug conjugates; ADC; acquisition; oncology; Rina-S
CSL Commits $117M for Option to Acquire VarmX and Advance Novel Blood Clotting Therapy to Market
CSL; VarmX; VMX-C001; blood clotting drug; Factor Xa inhibitors; anticoagulants; Phase 3 clinical trial; acquisition; biotech partnership; critical bleeding; FDA fast-track
FDA Crackdown on Pharma TV Ads Targets Pfizer, Novartis, BMS, Lilly & Others
FDA crackdown; pharma TV ads; Pfizer; Novartis; BMS; Lilly; warning letters; direct-to-consumer advertising; adequate provision rule; drug marketing compliance